Clinical trial
Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins
NCT00055159 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00055159 |
|---|---|
| Title | Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins |
| Official title | Treatment of Jugular, Subclavian, and/or Innominate Vein Thrombosis With Low Dose Recombinant Tissue Plasminogen Activator Plus Anticoagulation |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Thrombosis |
| Intervention type | Procedure |
| Interventions | Pulse-sprayed injection of recombinant tissue plasminogen activator (rtPA) |
| Enrollment | 50 |
| Start date | Feb 19, 2003 |
| Completion | Dec 10, 2007 |
| First posted | Feb 20, 2003 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: